Learn more about whether Elastic N.V. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

BMO Capital's revised price target suggests a positive outlook for Vertex's financial performance, driven by its latest product offering in the acute pain treatment landscape. With revenue growth ...

TD Cowen's analysis suggests that with the upcoming product launches and the strength of Vertex's pipeline, the company is well-positioned for sustained growth in the coming years. With analyst ...

Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, reveals that while free, easy product returns are paramount for consumer loyalty, they ...

Vertex reported solid fourth-quarter numbers ... Learn More » However, the "other product revenue" category could start to become more of a factor. Both the Alyftrek CF treatment and Jornavx ...

Vertex Impress Aqua is the latest product of Vertex released in November ... Taking connectivity into consideration, the phone has b, g, n, n 5GHz, Dual band, Wi-Fi Hotspot, Wi-Fi Direct with ...

Vertex Impress Vira is the latest product of Vertex released in November ... Taking connectivity into consideration, the phone has b, g, n, n 5GHz, Dual band, Wi-Fi Hotspot, Wi-Fi Direct with ...